The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681

Condition	Treatment or Intervention	Phase
Cocaine-Related Disorders	Drug: Cocaine-Related Disorders	Phase I

Further Study Details: 

Expected Total Enrollment:  20

Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681

Ages Eligible for Study:  18 Years   -   45 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

Includes but is not limited to:

• Non-treatment seekers
• DSM-IV criteria for cocaine abuse or dependence
• Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements

Exclusion Criteria:

Please contact site for more information.

Maryland
      Uniformed Services University of Health Science, Bethesda,  Maryland,  20814 4799,  United States; Recruiting

Study chairs or principal investigators

Louis Cantilena, M.D.,  Principal Investigator,  Uniformed Services University of Health Science   

Study ID Numbers:  NIDA-CPU-0003-1
Record last reviewed:  February 2005
Last Updated:  February 24, 2005
Record first received:  August 21, 2003
ClinicalTrials.gov Identifier:  NCT00067535
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08